SEARCH

SEARCH BY CITATION

References

  • 1
    O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tam KC, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. J Hepatol 1992; 14: 104111.
  • 2
    Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 18421847.
  • 3
    Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H. Retransplantation for hepatitis B—a multicenter experience. Transplantation 1994; 57: 823826.
  • 4
    Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619626.
  • 5
    Gugenheim J, Crafa F, Fabiani P, Goubaux B, Ouzan D, Mouiel J, et al. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients. Transplant Proc 1993; 25: 13491350.
  • 6
    Mora NP, Klintmalm GB, Poplawski SS, Cofer JB, Husberg BS, Gonwa TA, et al. Recurrence of hepatitis B after liver transplantation. Does hepatitis-B-immunoglobulin modify the recurrent disease? Transplant Proc 1990; 22: 15491550.
  • 7
    Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, et al. Liver transplantation for HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13: 9096.
  • 8
    Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312323.
  • 9
    Lavine JE, Lake JR, Ascher NL, Ferrell LD, Ganem D, Wright TL. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation. Gastroenterology 1991; 100: 263267.
  • 10
    Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19: 612.
  • 11
    Wright HI, Gavaler JS, Van Thiel DH. Preliminary experience with a-2b-interferon therapy in viral hepatitis in allograft recipients. Transplantation 1992; 53: 121124.
  • 12
    Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, et al. Hepatitis B virus and apparent non-A, non-B hepatitis. Lancet 1992; 339: 952955.
  • 13
    Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 773779.
  • 14
    Lugwig J. The nomenclature of chronic viral hepatitis: an obituary. Gastroenterology 1993; 103: 274278.
  • 15
    Dousset B, Conti F, Houssin D, Calmus Y. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients. N Engl J Med 1994; 330: 11601161.
  • 16
    Kovarik J, Mayer G, Pohanka E, Schwarz M, Traindl O, Graf H, et al. Adverse effect of low-dose prophylactic human recombinant leucocyte interferon-alpha treatment in renal transplant recipients. Transplantation 1988; 45: 402405.
  • 17
    Kramer P, Ten Kate FJW, Bijnen AB, Jeekel J, Weimar W. The pathology of interferon-induced renal allograft lesions. Transplant Proc 1985; 17: 5860.
  • 18
    Magnone M, Holley JL, Shapiro R, Scantlebury V, McCauley J, Jordan M, et al. Interferon-a-induced acute renal allograft rejection. Transplantation 1995; 59: 10681070.